Emcure Pharmaceuticals Limited — Guaifenesin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Guaifenesin · $645.9K export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #7 Indian exporter of Guaifenesin with $645.9K in export value and 46 verified shipments. Emcure Pharmaceuticals Limited holds a 2.4% market share in Guaifenesin exports across 11 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Guaifenesin Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Guaifenesin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MAURITIUS | $134.2K | 12 | 20.6% |
| KYRGYZSTAN | $98.1K | 5 | 15.1% |
| MYANMAR | $97.1K | 4 | 14.9% |
| TAJIKISTAN | $50.0K | 1 | 7.7% |
| FRANCE | $44.5K | 2 | 6.8% |
| ZIMBABWE | $42.7K | 4 | 6.6% |
| MOZAMBIQUE | $42.5K | 2 | 6.5% |
| KYRGHYSTAN | $37.9K | 1 | 5.8% |
| ZAMBIA | $34.4K | 8 | 5.3% |
| CONGO D REPULIC | $29.8K | 1 | 4.6% |
Emcure Pharmaceuticals Limited exports Guaifenesin to 13 countries. The largest destination is MAURITIUS accounting for 20.6% of Emcure Pharmaceuticals Limited's Guaifenesin shipments, followed by KYRGYZSTAN (15.1%) and MYANMAR (14.9%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Guaifenesin from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FARMAMIR LLC | KYRGHYSTAN | $79.1K | 3 |
| THE MAURITIUS PHARMACY SEEGOBIN L | MAURITIUS | $65.0K | 4 |
| THE MAURITIUS PHARMACY (SEEGOBIN) L | MAURITIUS | $50.0K | 2 |
| KARIM PHARM LLC | TAJIKISTAN | $50.0K | 1 |
| GRACE WIN CO.,LTD. | MYANMAR | $50.0K | 2 |
| KHETAN COMPANY LIMITED | MYANMAR | $47.1K | 2 |
| NEW AVAKASH INTERNATIONAL | ZIMBABWE | $42.7K | 4 |
| MEDIS FARMACEUTICA LDA | MOZAMBIQUE | $42.5K | 2 |
| GALAXY PHARMACEUTIQUE CORP. | CONGO D REPULIC | $29.8K | 1 |
| NEMAN FARM LLC. | KYRGYZSTAN | $25.8K | 1 |
Emcure Pharmaceuticals Limited supplies Guaifenesin to 21 buyers globally. The largest buyer is FARMAMIR LLC (KYRGHYSTAN), followed by THE MAURITIUS PHARMACY SEEGOBIN L (MAURITIUS) and THE MAURITIUS PHARMACY (SEEGOBIN) L (MAURITIUS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Guaifenesin Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $19.9M worth of Guaifenesin through 1,050 shipments from 151 suppliers to 77 countries, serving 278 buyers globally. Emcure Pharmaceuticals Limited contributes $645.9K to this total, accounting for 2.4% of India's Guaifenesin exports. Emcure Pharmaceuticals Limited ships Guaifenesin to 13 countries through 21 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Guaifenesin Exports?
Emcure Pharmaceuticals Limited's average Guaifenesin shipment value is $14.0K per consignment, based on 46 shipments totaling $645.9K. The largest destination is MAURITIUS (20.6% of Emcure Pharmaceuticals Limited's Guaifenesin exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Guaifenesin Exporters?
Emcure Pharmaceuticals Limited ranks #7 among 151 Indian Guaifenesin exporters with a 2.4% market share. The top 3 exporters are GRANULES INDIA LIMITED ($9.1M), ELYSIUM PHARMACEUTICALS LTD ($3.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($899.7K). Emcure Pharmaceuticals Limited processed 46 shipments to 11 destination countries.
What Guaifenesin Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS PRODUCTS VIFEX SYRUP 100 ML BT ( SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE & GUAIFENESIN | $141.6K | 12 |
| PHARMACEUTICAL PRODUCTS - VIFEX SYRUP 100 ML BT ( SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE & GUAIFENESIN SYRUP 1MG/ | $72.4K | 3 |
| PHARMACEUTICALS PRODUCTS VIFEX SYRUP 150ML BT SALBUTAMOL SULPHATE BROMHEXINEHYDROCHLORIDE GUAIFENESIN SYRUP 1MG 2 | $65.0K | 4 |
| PHARMACEUTICALS ARTICLE / ODS / PRODUCT / ITEM VIFEX SYRUP 100ML BT SALBUTAMOL SULPHATE, BROMHEXINEHYDROCHLORIDE & GUAIFENESIN SYRUP 1MG/2 | $50.0K | 1 |
| PHARMACEUTICALS PRODUCTS - VIFEX SYRUP 150 ML BT ( SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE & GUAIFENESIN SYRUP 1MG | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS - VIFEX L SYRUP100ML ( LEVOSALBUTAMOL SULPHATE, AMBROXOL HYDROCHLORIDE & GUAIFENESIN SYRUP 0.5M | $50.0K | 1 |
| PHARMACEUTICALS PRODUCTS VIFEX SYRUP 100ML BT SALBUTAMOL SULPHATE BROMHEXINEHYDROCHLORIDE GUAIFENESIN SYRUP 1MG 2 | $37.9K | 1 |
| PHARMACEUTICALS PRODUCTS VIFEX SYRUP 100ML BT ( SALBUTAMOL SULPHATE, BROMHEXINEHYDROCHLORIDE & GUAIFENESIN SYRUP 1MG/2 | $35.8K | 3 |
| VIFEX SYRUP 100ML BOTTLES (SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE & GUAIFENESIN SYRUP 1mg/2mg/50mg) | $29.8K | 1 |
| PHARMACEUTICALS PRODUCTS - VIFEX SYRUP 100 ML BT ( SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE & GUAIFENESIN SYRUP 1MG | $25.9K | 1 |
Emcure Pharmaceuticals Limited exports 24 distinct Guaifenesin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS PRODUCTS VIFEX SYRUP 100 ML BT ( SALBUTAMOL with 12 shipments worth $141.6K.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Guaifenesin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | BRAWN LABORATORIES LIMITED | $793.2K | 24 | 2 | $33.1K |
| 5 | AGIO PHARMACEUTICALS LIMITED | $781.2K | 34 | 3 | $23.0K |
| 7 | EMCURE PHARMACEUTICALS LIMITED ★ | $645.9K | 46 | 11 | $14.0K |
| 8 | GLENMARK PHARMACEUTICALS LIMITED | $594.8K | 30 | 7 | $19.8K |
| 9 | MARKSANS PHARMA LIMITED | $576.5K | 28 | 3 | $20.6K |
Emcure Pharmaceuticals Limited ranks #7 among 151 Indian Guaifenesin exporters. Average shipment value of $14.0K compared to the market average of $131.8K. The closest competitors by value are BRAWN LABORATORIES LIMITED and AGIO PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Guaifenesin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 118 | 11.2% |
| NHAVA SHEVA SEA (INNSA1) | 94 | 9.0% |
| JNPT | 74 | 7.0% |
| JNPT/ NHAVA SHEVA SEA | 70 | 6.7% |
| HYDERABAD AIR | 53 | 5.0% |
| HYDERABAD ICD (INSNF6) | 50 | 4.8% |
| MUNDRA SEA (INMUN1) | 50 | 4.8% |
| MUNDRA SEA | 47 | 4.5% |
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Guaifenesin Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Guaifenesin, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Guaifenesin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Guaifenesin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 47 individual customs records matching Emcure Pharmaceuticals Limited exporting Guaifenesin, covering 24 formulations to 13 countries via 21 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 278+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Guaifenesin Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Guaifenesin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Guaifenesin Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Guaifenesin. For current shipment-level data, contact TransData Nexus.